Braintree Labs v. Schwarz Pharma, Inc., __ F.Supp.2d __, No. 03-477-SLR, 2008 WL 2944655 (D. Del. July 31, 2008)

In a July 31, 2008 decision, the District Court of Delaware rejected antitrust and unjust enrichment claims by a generic drug manufacturer for failing to satisfy the “sham litigation” exception to the Noerr-Pennington Doctrine. Braintree Labs v. Schwarz Pharma, Inc., __ F.Supp.2d __, No. 03-477-SLR, 2008 WL 2944655 (D. Del. July 31, 2008).

Continue Reading...
Tags:

Ninth Circuit Affirms Dismissal Of Foreign DRAM Purchaser's Price-Fixing Claim For Lack Of Subject-Matter Jurisdiction Under The Foreign Trade Antitrust Improvement Act

On August 14, 2008, the United States Court of Appeals for the Ninth Circuit affirmed a district court's dismissal for lack of subject-matter jurisdiction of a foreign DRAM purchaser's claim of price fixing against defendant DRAM manufacturers.  In re Dynamnic Random Access Memory (DRAM) Antitrust Litig., No. 06-15636 (9th Cir. 8-14-2008).

Continue Reading...
Tags: